Page results
-
Simon Porter joined UCLH as a non-executive director on 1 April 2020. He is a chartered accountant whose executive career at the London office of Ernst & Young ranged across audit, corporate finance and risk management.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
-
UCLH is to trial the COVID-19 vaccine developed by University of Oxford in healthy staff volunteers.
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
Elective Placements and visiting doctors at The Hospital for Tropical Diseases
-
Winning the award - Sarcoma Healthcare Professionals Innovation and Excellence – CNS London Sarcoma Service, The National Sarcoma Educational Programme. Jo and Anne had the vision of sharing a regular in-house education session to bring sarcoma nurses and doctors together. These monthly sessions have seen a broad range of speakers and experts in the sarcoma field from other sarcoma units, charities and researchers sharing their knowledge.
-
Subscribe to updates from The Red Cell Network
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
File results
-
FOI/2024/0068 - Pilots of virtual wards remote monitoring solutions
-
FOI/2024/0069 - Staff bank contact details
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0081 - Consultant doctors headcount
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023